News & Articles

New research suggests that metal-based chemotherapies eliminate inhibitory components of the immune system

Dr. Richard M. Eglen of Corning Life Sciences shares expertise on optimizing 3D cell culture assays with the latest technologies

Dr. Masato Nakagawa to discuss induced pluripotent stem cells for regenerative research

Join this free webinar to learn how to measure neuronal and network activity using calcium imaging

Visit Repositive at booth B6 in the Exhibit Hall at EORTC-NCI-AACR 2018 to learn about cutting-edge 3D organoid technologies

Catch a space in our free, educational webinar on mitigating contamination in cell culture workflows

New technology enables production of biologically relevant cells to create human models for drug development

Findings presented at ASHG 2018 annual meeting shed light on the biology behind type-2 asthma

AstraZeneca scientist Dr. David Baker discusses live-cell imaging techniques for drug discovery applications, and how to optimize your assay development

6 ways to improve and accelerate your methods in cell-based assays - a SelectScience editorial special feature

Join SelectScience and Dr. Richard Eglan for a specialist drug discovery webinar on 3D cell culture technology

New human hair cell discovery will make it possible to develop new treatment methods for hearing impairment

New 3D model provides options for drug development and treatment of gestational disorders

Discover how 3D models of glioblastoma using patient-derived stem cells could enable more effective treatment

AMSBIO has announced an exosome isolation, manufacturing, and characterization service to enable R&D groups to accelerate their discovery and development activities

The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells

New collaboration with INRA Micalis-MGP will concentrate on DuPont’s probiotic strains and the understanding of these microbes’ mechanism of action on human health

AMSBIO’s new cell culture medium offers better conditions for induced pluripotent and embryonic stem cells, study shows

How cross-functional collaboration between academia and industry is advancing drug discovery in the ULTRA-DD program

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

Attend Miltenyi Biotec’s symposium to learn how researchers are tackling tumor heterogeneity with single-cell-analysis